This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Godavari Biorefineries Limited. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Vitthal Yadav: Innovator in Anticancer Compounds
Introduction
Vitthal Yadav is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of cancer research through his innovative work on anticancer compounds. With a total of 2 patents to his name, Yadav is dedicated to advancing medical science and improving treatment options for cancer patients.
Latest Patents
Yadav's latest patents focus on the development of compounds that inhibit uncontrolled cell proliferation, particularly in cancer stem cells. These inventions are crucial for the treatment of various types of cancer, including breast and prostate cancer. The compounds he has developed are categorized under specific formulas, namely Formula III to XIV, which are designed to target and combat cancer effectively.
Career Highlights
Vitthal Yadav is currently associated with Godavari Biorefineries Limited, where he applies his expertise in research and development. His work is instrumental in pushing the boundaries of what is possible in cancer treatment. Yadav's commitment to innovation is evident in his ongoing research and the impact of his patents on the medical community.
Collaborations
Yadav collaborates with talented individuals in his field, including coworkers Sandip Gavade and Smera Satish. These partnerships enhance the research environment and foster the exchange of ideas, which is vital for innovation.
Conclusion
Vitthal Yadav is a prominent figure in the realm of cancer research, with a focus on developing effective treatments through his patented compounds. His work not only contributes to scientific knowledge but also holds the potential to improve the lives of countless individuals affected by cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile